Literature DB >> 18068745

Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative.

Katalin Prokai-Tatrai1, Pal Perjesi, Nilka M Rivera-Portalatin, James W Simpkins, Laszlo Prokai.   

Abstract

Antioxidant action is an important component of the complex neuroprotective effect of estrogens. Combining theoretical prediction and subsequent experimental confirmation by chemical and in vitro paradigms, this study focused on the mechanistic aspects of hydroxyl radical scavenging by 17beta-butoxy-1,3,5(10)-estratrien-3-ol, a synthetic derivative of 17beta-estradiol with increased potency to inhibit lipid peroxidation and reduced affinity to estrogen-receptors compared to the endogenous hormone. In the process that acts as a "chemical shield," the phenolic A-ring turns into 10beta-hydroxy-17beta-butoxy-1,3,5(10)-estratrien-3-one, a non-aromatic para-quinol, upon capturing hydroxyl radicals, which results in the complete loss of estrogen-receptor affinity and antioxidant activity. However, the parent compound is apparently recovered in brain tissue from this para-quinol via enzyme-catalyzed NAD(P)H-dependent reductive aromatization without causing oxidative stress. Taken together, our report argues for a previously unrecognized antioxidant cycle for estrogen-derived compounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068745      PMCID: PMC2317824          DOI: 10.1016/j.steroids.2007.10.011

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  40 in total

1.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

Authors:  B Moosmann; C Behl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Cyclohexadienone ketals and quinols: four building blocks potentially useful for enantioselective synthesis.

Authors:  D Magdziak; S J Meek; T R R Pettus
Journal:  Chem Rev       Date:  2004-03       Impact factor: 60.622

Review 3.  Impact of metabolism on the safety of estrogen therapy.

Authors:  Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

4.  Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle-aged ovariectomized female rats.

Authors:  Heather A Bimonte-Nelson; Kevin R Francis; Claudia D Umphlet; Ann-Charlotte Granholm
Journal:  Eur J Neurosci       Date:  2006-07       Impact factor: 3.386

5.  Direct observation of a free radical interaction between vitamin E and vitamin C.

Authors:  J E Packer; T F Slater; R L Willson
Journal:  Nature       Date:  1979-04-19       Impact factor: 49.962

Review 6.  Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.

Authors:  Darrell W Brann; Krishnan Dhandapani; Chandramohan Wakade; Virendra B Mahesh; Mohammad M Khan
Journal:  Steroids       Date:  2007-02-21       Impact factor: 2.668

Review 7.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

8.  An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage.

Authors:  L M Nutter; Y Y Wu; E O Ngo; E E Sierra; P L Gutierrez; Y J Abul-Hajj
Journal:  Chem Res Toxicol       Date:  1994 Jan-Feb       Impact factor: 3.739

Review 9.  Lipoprotein-associated estrogens.

Authors:  Matti J Tikkanen; Veera Vihma; Matti Jauhiainen; Anna Höckerstedt; Hannamaarit Helisten; Maija Kaamanen
Journal:  Cardiovasc Res       Date:  2002-11       Impact factor: 10.787

Review 10.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

View more
  23 in total

1.  Simultaneous Measurement of 17β-Estradiol, 17α-Estradiol and Estrone by GC-Isotope Dilution MS/MS.

Authors:  Katalin Prokai-Tatrai; Darius Bonds; Laszlo Prokai
Journal:  Chromatographia       Date:  2010-02       Impact factor: 2.044

2.  An exploratory investigation of brain-selective estrogen treatment in males using a mouse model of Alzheimer's disease.

Authors:  Anna E Tschiffely; Rosemary A Schuh; Katalin Prokai-Tatrai; Mary Ann Ottinger; Laszlo Prokai
Journal:  Horm Behav       Date:  2017-12-22       Impact factor: 3.587

3.  Estrogen protection in Friedreich's ataxia skin fibroblasts.

Authors:  Timothy E Richardson; Shao-Hua Yang; Yi Wen; James W Simpkins
Journal:  Endocrinology       Date:  2011-05-03       Impact factor: 4.736

Review 4.  Therapeutic strategies in Friedreich's ataxia.

Authors:  Timothy E Richardson; Heather N Kelly; Amanda E Yu; James W Simpkins
Journal:  Brain Res       Date:  2013-04-13       Impact factor: 3.252

5.  Smooth muscle relaxation and activation of the large conductance Ca(++)-activated K+ (BK(Ca)) channel by novel oestrogens.

Authors:  J Maher; A C Hunter; J G Mabley; J Lippiat; M C Allen
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

6.  The utility of oligopeptidase in brain-targeting delivery of an enkephalin analogue by prodrug design.

Authors:  K Prokai-Tatrai; H-S Kim; L Prokai
Journal:  Open Med Chem J       Date:  2008-10-20

7.  Neuroprotective actions of the synthetic estrogen 17alpha-ethynylestradiol in the hippocampus.

Authors:  Ofir Picazo; Adriana Becerril-Montes; Delia Huidobro-Perez; Luis M Garcia-Segura
Journal:  Cell Mol Neurobiol       Date:  2010-01-01       Impact factor: 5.046

Review 8.  Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens.

Authors:  James W Simpkins; Kun Don Yi; Shao-Hua Yang
Journal:  Front Neuroendocrinol       Date:  2009-05-03       Impact factor: 8.606

9.  Relationship between estradiol and antioxidant enzymes activity of ischemic stroke.

Authors:  Nasrin Sheikh; Heidar Tavilani; Aliakbar Rezaie; Asad Vaisi-raygani; Saeedeh Salimi
Journal:  J Biomed Biotechnol       Date:  2009-09-02

10.  Quantitative structure-activity relationships predicting the antioxidant potency of 17β-estradiol-related polycyclic phenols to inhibit lipid peroxidation.

Authors:  Laszlo Prokai; Nilka M Rivera-Portalatin; Katalin Prokai-Tatrai
Journal:  Int J Mol Sci       Date:  2013-01-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.